Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advanced Medical Inc. reports fourth quarter and 1995 results.


SAN DIEGO--(BUSINESS WIRE)--March 19, 1996--Advanced Medical Inc. (ASE (Adaptive Server Enterprise) A relational DBMS from Sybase that runs on Windows NT/2000, Linux and a variety of Unix platforms. ASE is a comprehensive and robust data management product with a long history dating back to the late 1980s. :AMA (Automatic Message Accounting) The recording and reporting of telephone calls within a telephone system. It includes the calling and called parties and start and stop times of the call. ) Tuesday Tuesday: see week.  announced financial results for the fourth quarter and year ended Dec. 31, 1995.

For the three months ended Dec. 31, 1995, income before taxes and minority interests rose 12% to $3,240,000 from $2,897,000 for the fourth quarter of 1994 on revenue of $29,429,000 versus $29,671,000 a year earlier.

After a one-time one-time
adj.
1. or one·time
a. Occurring or undertaken only once: a one-time winner in 1995.

b.
 income tax benefit of $10,070,000 primarily related to the recognition of deferred tax assets under Statement of Financial Accounting Standards No. 109 (SFAS SFAS Statement of Financial Accounting Standards
SFAS Special Forces Assessment and Selection
SFAS Student Financial Aid Services
SFAS Sport Fishing Association of Singapore
SFAS Safety Features Actuation System
SFAS Statewide Fixed Assets System
 109), a $6,500,000 charge reflecting the write-up Write-Up

An increase made to the book value of an asset because it is undervalued compared to market values.

Notes:
A write-up will increase a company's accounting book value without any expenditures.
 of minority interests, and dividends and accretions accretions (krē´shnz),
n.
 of $163,000 on the Company's mandatorily redeemable Redeemable

Eligible for redemption under the terms of an indenture.
 preferred stock Stock shares that have preferential rights to dividends or to amounts distributable on liquidation, or to both, ahead of common shareholders.

Preferred stock is given preference over common stock. Holders of preferred stock receive dividends at a fixed annual rate.
, net income for the fourth quarter of 1995 was $6,647,000, or $.19 per fully-diluted common share. This compares to net income of $2,022,000, or $.08 per share, for the fourth quarter of 1994.

"We have stabilized sta·bi·lize  
v. sta·bi·lized, sta·bi·liz·ing, sta·bi·liz·es

v.tr.
1. To make stable or steadfast.

2.
 our core hospital infusion management business, re-established momentum in our in-house In-house

In the context of general equities, keeping an activity within the firm. For example, rather than go to the marketplace and sell a security for a client to anyone, an attempt is made to find a buyer to complete the transaction with the firm.
 product development program, set the Company on a path of sustained profitability, and significantly reduced debt and improved cash flow," said Joseph W. Kuhn Kuhn , Richard 1900-1967.

Austrian chemist. He won a 1938 Nobel Prize for research on carotenoids and vitamins but declined the award by order of the Nazi government.
, president of Advanced Medical.

"Now we are in a position to accelerate our efforts to grow the Company. In addition to offering enhancements and additions to our highly successful family of hospital infusion pump infusion pump A device designed to deliver drugs and/or 'biologicals', at low doses and at a constant or controllable rate; ↑ rates of delivery in such devices may be associated with local hemolysis, compromising the potential benefits of a calibrated delivery  products, during 1996 we will enter the burgeoning ambulatory Movable; revocable; subject to change; capable of alteration.

An ambulatory court was the former name of the Court of King's Bench in England. It would convene wherever the king who presided over it could be found, moving its location as the king moved.
 infusion pump market with the U.S. launch of an advanced micro infusion pump developed by Debiotech, S.A. We currently are evaluating additional strategic alliances that will leverage our manufacturing and sales capabilities and enhance our presence in foreign markets. We are optimistic op·ti·mist  
n.
1. One who usually expects a favorable outcome.

2. A believer in philosophical optimism.



op
 about Advanced Medical's performance in the new year," he added.

For the twelve months ended Dec. 31, 1995, income before taxes, minority interests, and an extraordinary gain rose 24% to $9,403,000 from $7,563,000 for 1994. Revenue for 1995 was $112,110,000 compared to $111,681,000 for the prior year.

After the one-time tax benefit and minority interest adjustment described above, an extraordinary gain of $15,177,000 after tax, or $.46 per share, from the early extinguishment The destruction or cancellation of a right, a power, a contract, or an estate.

Extinguishment is sometimes confused with merger, though there is a clear distinction between them.
 of debt, and dividends and accretions of $650,000 on the preferred stock, net income for 1995 was $26,804,000, or $.83 per fully-diluted common share. This compares to net income of $4,803,000, or $.22 per fully-diluted common share, for 1994.

At Dec. 31, 1995, AMA reported working capital of $31,938,000, a current ratio of 2.2-to-1, and shareholders' equity Shareholders' Equity

A firms' total assets minus its total liabilities. Equivalently, it is share capital plus retained earnings minus treasury shares. Shareholders' equity is the amount by which a company is financed through common and preferred shares.
 of $31,532,000 compared to a deficit of $2,238,000 at Dec. 31, 1994. "The early retirement of debt, coupled with AMA's significantly improved profitability, allowed us to reduce long-term debt Long-Term Debt

Loans and financial obligations lasting over one year.

Notes:
For example debts obligations such as bonds and notes which have maturities greater than one year would be considered long-term debt.
, net of cash, by more than $30,000,000 during 1995," Kuhn concluded.

Advanced Medical, through its IMED IMED International Medical Education Directory  Corporation subsidiary, is one of the country's largest manufacturers of intravenous intravenous /in·tra·ve·nous/ (-ve´nus) within a vein or veins.intrave´nously

in·tra·ve·nous
adj. Abbr. IV
Within or administered into a vein.
 infusion pumps and disposable disposable Nursing adjective Referring to that which is discarded or disposed of noun An item used in health care-related Pt contact which is discarded after use–eg masks, gloves, gowns, needles, paper products, syringes, wipes. See Biohazardous waste.  administration sets. -0-
                         Advanced Medical Inc.
            Condensed Consolidated Statements of Operations
           (In thousands, except per share data.  Unaudited)


                                             Three Months Ended
                                                  Dec. 31,
                                               1994      1995
     Sales                                  $ 29,671  $ 29,429
     Cost of sales                            17,142    16,624
       Gross margin                           12,529    12,805
     License fees revenue                        110       110


     Selling expenses                          4,171     3,602
     General and administrative expenses       2,364     2,964
     Research and development expenses         1,874     1,783


       Total operating expenses                8,409     8,349


       Income from operations                  4,230     4,566
     Other income (expense):
       Interest income                           636       711
       Interest expense                       (2,030)   (1,969)
       Other, net                                 61       (68)
                                              (1,333)   (1,326)
     Income before income taxes, minority
      interests and extraordinary item         2,897     3,240
     Income tax provision (benefit)              717   (10,070)


     Income before minority interests
      and extraordinary item                   2,180    13,310
     Minority interests in consolidated
      subsidiaries                                --    (6,500)


     Income before extraordinary item          2,180     6,810
     Extraordinary item-
      gain on early retirement of debt            --        --


     Net income                                2,180     6,810
     Dividends and accretion on mandatorily
      redeemable preferred stock                 158       163


     Net income applicable to common stock  $  2,022  $  6,647
     Income per common share
      assuming no dilution:
        Income before extraordinary item    $    .14  $    .40
        Extraordinary item                        --        --
            Net income per common share
              assuming no dilution          $    .14  $    .40
     Income per common share
      assuming full dilution:
        Income before extraordinary item    $    .08  $    .19
        Extraordinary item                        --        --
            Net income per common share
             assuming full dilution         $    .08  $    .19
     Weighted average common shares
       outstanding assuming no dilution       14,069    16,513
     Weighted average common shares
      outstanding assuming full dilution      30,553    35,996
-0-


                         Advanced Medical Inc.
          Condensed Consolidated Statements of Operations
         (In thousands, except per share data.  Unaudited)


                                            Twelve Months Ended
                                                  Dec. 31,
                                              1994      1995
     Sales                                  $111,681  $112,110
     Cost of sales                            65,590    63,219
       Gross margin                           46,091    48,891
     License fees revenue                        441       441


     Selling expenses                         16,850    16,567
     General and administrative expenses      10,746    10,661
     Research and development expenses         6,345     7,386


       Total operating expenses               33,941    34,614


       Income from operations                 12,591    14,718
     Other income (expense):
       Interest income                         2,526     2,525
       Interest expense                       (8,690)   (8,153)
       Other, net                              1,136       313
                                              (5,028)   (5,315)
     Income before income taxes, minority
      interests and extraordinary item         7,563     9,403
     Income tax provision (benefit)            1,886    (9,374)


     Income before minority interests
      and extraordinary item                   5,677    18,777
     Minority interests in consolidated
      subsidiaries                                --    (6,500)


     Income before extraordinary item          5,677    12,277
     Extraordinary item-
      gain on early retirement of debt            --    15,177


     Net income                                5,677    27,454
     Dividends and accretion on mandatorily
      redeemable preferred stock                 874       650


     Net income applicable to common stock  $  4,803  $ 26,804
     Income per common share
      assuming no dilution:
        Income before extraordinary item    $    .34  $    .74
        Extraordinary item                        --       .96
            Net income per common share
              assuming no dilution          $    .34  $   1.70
     Income per common share
      assuming full dilution:
        Income before extraordinary item    $    .22  $    .37
        Extraordinary item                        --       .46
            Net income per common share
             assuming full dilution         $    .22  $    .83
     Weighted average common shares
       outstanding assuming no dilution       14,069    15,755
     Weighted average common shares
      outstanding assuming full dilution      24,099    33,183


CONTACT: Advanced Medical Inc.

Joseph W. Kuhn, 619/566-0426
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 19, 1996
Words:1032
Previous Article:Sizzler International reports third quarter results.
Next Article:TRANS WORLD ENTERTAINMENT REPORTS FOURTH QUARTER AND YEAR-END 1995 RESULTS; SALES CONSISTENT WITH STRATEGIC PLAN.
Topics:



Related Articles
MEDICAL TECHNOLOGY SYSTEMS ANNOUNCES YEAR-END RESULTS.
Novametrix records substantial earnings growth.
HEALTHDYNE TECHNOLOGIES ANNOUNCES 1995 FINANCIAL RESULTS.
FluoroScan reports 4th quarter/year end results.
PHYSICIAN SALES & SERVICE, INC. REPORTS RECORD FOURTH QUARTER SALES AND EARNINGS.
NOVAMETRIX reports fiscal 1996 increases.
Sunrise Medical reports fiscal 1996 financial results and sale of Comfort Clinic.
SPAN-AMERICA REPORTS RESULTS FOR FOURTH QUARTER OF FISCAL 1996; DECLARES QUARTERLY DIVIDEND.
Maxxim Medical reports results for fiscal 1996.
CardioVascular Dynamics announces 113 percent increase in revenues.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles